![Timothy Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Kelly
Directeur Technique/Scientifique/R&D chez
CARIBOU BIOSCIENCES, INC.
Fortune : 172 575 $ au 31/05/2026
Profil
Timothy P.
Kelly currently works at Caribou Biosciences, Inc., as Chief Technology Officer from 2024.
Mr. Kelly also formerly worked at Oxford Biomedica Solutions LLC, as Chairman & Chief Executive Officer from 2022 to 2023, Biogen, Inc., as Senior Director-International Operations from 1998 to 2005, Sarepta Therapeutics, Inc., as Head-Technical Operations in 2017, Shire Plc, as Senior Vice President & Head-Biologics Operating from 2016 to 2017, UCB SA, as Head-Technical Operations from 2005 to 2009, and Homology Medicines, Inc., as Chief Operating Officer from 2021 to 2022.
Mr. Kelly received his undergraduate degree from United States Air Force Academy and Masters Business Admin degree from Troy University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/02/2026 | 73 125 ( 0,07 % ) | 172 575 $ | 31/05/2026 |
Postes actifs de Timothy Kelly
| Sociétés | Poste | Début |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 07/01/2024 |
Anciens postes connus de Timothy Kelly
| Sociétés | Poste | Fin |
|---|---|---|
Oxford Biomedica Solutions LLC
 Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Directeur Général | 01/07/2023 |
| Q32 BIO INC. | Directeur des opérations | 10/03/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/05/2017 |
| SHIRE | Corporate Officer/Principal | 01/01/2017 |
| UCB | Corporate Officer/Principal | 01/01/2009 |
Formation de Timothy Kelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
United States Air Force Academy
 United States Air Force Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Troy University
 Troy University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
Oxford Biomedica Solutions LLC
Oxford Biomedica Solutions LLC Industrial MachineryProducer Manufacturing Operates as an AAV focused manufacturing and innovation company | Producer Manufacturing |
